We Venture Capital

An exciting month for our team as we’ve been on the road connecting with the next generation of business leaders! Over the past few weeks, we've had the privilege of presenting sessions on VC funding & coporate investing at two prestigious business schools, IESE Business School and Esade, which per the Financial Times´s 2025 rankings published just this morning are both in the top 10 globally! It's been incredible engaging with passionate students, sharing our insights at the intersection of VC & Diagnostics, and discussing all things We Venture Capital ✨ Many thanks to IESE & Esade for hosting us along with the MBA students who participated in the events! #FutureLeaders #CorporateVC #Innovation #IESE #ESADE #VentureCapital

🔔 Less than one week to go until DxPx Conference EU´25 in Munich, Germany! We Venture Capital has been delighted to sponsor multiple editions of #DxPx over the years as the series has cemented its place as the leading conference for diagnostics & digital health start-ups globally. This January´s European installment is no exception! Anthony Vallance-Owen and Gökçe Gün, MD MBA from the We VC team will be attending along with Louise Warme who also participates in the #42PLUS1 judging panel during the event. 📍 42PLUS1 Finalist Live Pitch: Where Innovation Meets Opportunity 📅 27 January, 2-4pm CET Book a meeting with us via the DxPx partnering platform 👉  https://lnkd.in/eHKJBQpf See you there! #DxPx #LifeScienceTools #Diagnostics #StartupFunding #DxPx2025 #Diagnostics #DigitalHealth #PrecisionMedicine #LifeSciences #InvestorMeetings #PartneringOpportunities CC: Mirko Stange

📢 Exciting news from the We Venture Capital portfolio that deepull has received FDA Breakthrough Device Designation for their UllCORE Bloodstream Infection Test! This achievement is a major step in advancing their groundbreaking diagnostic platform, and we look forward to supporting their continued progress. 🔗 Read more at: https://lnkd.in/dXqTaD3P #Innovation #Healthcare #FDA #BreakthroughDesignations CC: Louise Warme Anthony Vallance-Owen Gökçe Gün, MD MBA Gemma Sturt

We are delighted to welcome Oxford Cancer Analytics (OXcan) to the We Venture Capital portfolio 🚀🔥   At We VC, we are committed to backing exceptional founders developing cutting-edge diagnostics for patients with critical medical need, and there’s no greater urgency than in the early detection of cancer. That’s why we´re thrilled to have co-led a $11m Series A into OXcan alongside Cross-Border Impact Ventures and participation from Eka Ventures, DigitalDx Ventures, Macmillan Cancer Support, Aurelium Ventures and OKG Capital.   OXcan is on a mission to drastically transform cancer early detection using frontier proteomics and ML approaches that can detect the deadliest cancers early, when they can still be cured. This blood test can be conducted in an affordable, minimally invasive, and routine manner with superior accuracy and localization capacity in large populations. OXcan has applied their biomarker discovery and validation platform starting from lung cancer, the leading cause of cancer mortality worldwide.   Head of We Venture Capital, Louise Warme, comments on the fund´s most recent investment: "The power of the OXcan proteomics biomarker discovery platform and the data generated by Oxcan stand out against the backdrop of other liquid biopsy companies, indicating a truly superior performance in the identification of early stage lung cancer. We have been very impressed by the team to date and look forward to supporting the company in the next phase of its growth to offer its first product to patients.” 🔗 Read more in the official press release, linked below in the comments About OXcan 👉 https://www.oxcan.org/ About We Venture Capital 👉 https://lnkd.in/eyvXpGZ4   CC: Anthony Vallance-Owen Gökçe Gün, MD MBA Richa Goswami Conor McKiernan Annie Theriault Cyriac M Alappat CPA,CA Jon Coker Michele Colucci, Esq. Felix Litzkow Peter Jianrui Liu Andreas Halner Daniel Szulc Marcus East Brad Wilson   #liquidbiopsy #cancercare #lungcancer #proteomics #AI #ML #venturecapital #healthtech #healthcare

✈️ Connect with us at JPM week in San Francisco this month! Gemma Sturt from the We Venture Capital team will be available to meet in person on 13-15th January during the J.P. Morgan Healthcare Conference. Reach out to book a meeting 👉 https://lnkd.in/eyvXpGZ4 See you there! #JPM2025 #JPM25 #Healthcare #VC #JPMHealthcare #SanFrancisco

We Venture Capital is pleased to announce its investment into Proton Intelligence in a heavily oversubscribed $6.95m Seed round alongside Tenmile, SOSV, LongeVC, 15th Rock, Exor Ventures, Trampoline Venture Partners and others. The company is developing the world´s first non invasive CKM™ for monitoring potassium levels of kidney patients. 1/3 of patients with chronic kidney disease or heart failure unnecessarily stop life-saving therapy after a high potassium event, which ultimately leads to a c.40% increase in 6-month mortality. Proton’s CKM™ technology aims to provide providers and patients accurate, remote, continuous potassium levels allowing precise treatment of these patients. “We Venture Capital have been impressed by this true breakthrough in electrolyte sensing capability, which will fulfil a critical gap in the current care continuum for many patients at risk from dyskalemia. We look forward to working with the Proton Intelligence team on the next phase of their journey” said Dr. Louise Warme, Head of We Venture Capital. Congratulations to Sahan Ranamukhaarachchi, Víctor J. Cadarso and the Proton Intelligence team! About Proton Intelligence 👉 https://lnkd.in/eVCwZ6Xu About We Venture Capital 👉 https://lnkd.in/eyvXpGZ4 CC: Louise Warme Anthony Vallance-Owen Gökçe Gün, MD MBA Richa Goswami Rory St Clair Gemma Sturt #healthcare #Seedround #VC #diagnostics #venturecapital #startups #fundraising

The We Venture Capital team, our Silver Sponsors, is on-site at their booth! 💙As Werfen's corporate venture arm, they invest in diagnostic start-ups and digital solutions, offering strategic support to help companies thrive. Visit their booth today and tomorrow or check out weventurecapital.com for details! Shout-out to the team: Anthony Vallance-Owen, Richa Goswami, Gemma Sturt, Gökçe Gün, MD MBA and Louise Warme!

We Venture Capital is a proud sponsor of #HTF2024 in Barcelona this week, hosted by Health Tech Forward! Meet We VC in person to discuss all things #diagnostics and #digitalhealth and hear the team speak at the following sessions: 📍 Anthony Vallance-Owen will be moderating the panel "Accessible diagnostics for oncology and more: how do we redefine disease detection?" alongside Annie Theriault (Cross-Border Impact Ventures), Marina Rigau (MiMARK Diagnostics) and Andreas Halner (Oxford Cancer Analytics) 📅11:30-12 CET, 4th December 📍 Gemma Sturt will be juding the Disruptive Diagnostics session as part of the Health Tech Challengers live pitch series 📅3-4pm CET, 4th December 📅3-4pm CET, 5th December (superfinals) 👉 Register via link in comments CC: Louise Warme Gökçe Gün, MD MBA Richa Goswami Bartė Šimaitytė Matas Globys #pitching #investorconference #healthtech #HealthTech #venturecapital #investment #startups #VC #lifesciences #medtech #AI #ArtificialIntelligence #PrecisionMedicine #LifeSciences

We VC is a proud sponsor of DxPx Conference, Europe’s largest investor conference for diagnostics, digital health & life science tools - with 100+ attending investors and counting! 📅 26-27 January 2025 📍 Munich, Germany   🔔 Don’t miss out on the opportunity to network, pitch, and partner with the We VC team and other industry leaders who are shaping the future of healthcare 💥 Act now: Submit your 42plus1 application before November 22nd to secure a €700 discount on your ticket! 👉 Register via https://lnkd.in/dav_JNH   Let’s innovate health together. See you in Munich! 🙌 #DxPx #LifeScienceTools #Diagnostics #StartupFunding CC: Gemma Sturt Anthony Vallance-Owen Louise Warme Gökçe Gün, MD MBA Mirko Stange

We Venture Capital portfolio company Capitainer proudly shares the launch of its blood sampling card Capitainer®SEP10 for obtaining separated blood from just a finger prick in home settings 🚀   🩸 With Capitainer´s technology, patients can collect a blood sample from themselves anytime and anywhere and send it by regular mail to the laboratory for analysis. We VC is thrilled to continue to support the company towards its goal of enabling decentralised precision blood sampling and widening access to healthcare diagnostics!   👉 company website: https://capitainer.com/ 👉 full press release in the comments #venturecapital #innovation #bloodsampling #fingerprick #diagnostics #Dx #HealthTech #MedTech